ESC 365 - Factors associated with delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

ESC Professional Premium Access

Factors associated with delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

Session: Atrial fibrillation stroke prevention with oral anticoagulants

Topic: Oral Anticoagulation

Speaker: Doctor X. Luo (Groton, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Xuemei Luo

Groton (United States of America)

0 follower

6 more presentations in this session

Impact of proton pump inhibitor on quality of anticoagulant control and outcomes in atrial fibrillation patients treated with an oral anticoagulant in the COOL-AF registry.

Speaker: Doctor P. Chichareon (Hat Yai, TH)

Comparative analysis of oral anticoagulation therapy in Asian patients with atrial fibrillation and end-stage renal disease: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)

Oral anticoagulation among frail patients with atrial fibrillation: assessment of net clinical benefit in a nationwide cohort

Speaker: Ms M. Soegaard (Aalborg, DK)

Relationship between care speciality and atrial fibrillation outcomes in the GARFIELD-AF registry

Speaker: Doctor C. Camm (Oxford, GB)

Plasma levels of direct oral anticoagulants in non-valvular atrial fibrillation patients at the time of acute cardioembolic or bleeding events

Speaker: Doctor G. Nemola (Milan, IT)

Access the full session

Atrial fibrillation stroke prevention with oral anticoagulants

Speakers: Doctor X. Luo, Doctor P. Chichareon, Doctor S. Lee, Ms M. Soegaard, Doctor C. Camm...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by